180 related articles for article (PubMed ID: 28728964)
1. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.
Lochhead P; Hagan K; Joshi AD; Khalili H; Nguyen LH; Grodstein F; Chan AT
Gastroenterology; 2017 Oct; 153(4):971-979.e4. PubMed ID: 28728964
[TBL] [Abstract][Full Text] [Related]
2. Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study.
Mehta RS; Kochar B; Zhou Z; Broder JC; Chung P; Yang K; Lockery J; Fravel M; Ryan J; Mahady S; Orchard SG; McNeil JJ; Murray A; Woods RL; Ernst ME; Chan AT
Gastroenterology; 2023 Sep; 165(3):564-572.e1. PubMed ID: 37315867
[TBL] [Abstract][Full Text] [Related]
3. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies.
Babic A; Zhang X; Morales-Oyarvide V; Yuan C; Khalaf N; Khalili H; Lochhead P; Chan AT; Ogino S; Wolpin BM; Wu K; Fuchs CS; Giovannucci EL; Stampfer MJ; Ng K
Br J Cancer; 2020 Sep; 123(5):844-851. PubMed ID: 32541871
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
[TBL] [Abstract][Full Text] [Related]
8. Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study.
Lim HJ; Oh IS; Noh Y; Yon DK; Shin JY
Medicine (Baltimore); 2024 Jan; 103(1):e36772. PubMed ID: 38181266
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitor Use and Cognitive Function in the Boston Puerto Rican Health Study.
Dinesh D; Lee JS; Scott TM; Tucker KL; Palacios N
J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(8):1461-1470. PubMed ID: 36420642
[TBL] [Abstract][Full Text] [Related]
10. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis.
Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM
Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350
[TBL] [Abstract][Full Text] [Related]
11. Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database.
Conrady CD; Pradeep T; Yu Y; Johnson MW; VanderBeek BL
Ophthalmol Retina; 2023 Mar; 7(3):261-265. PubMed ID: 36058521
[TBL] [Abstract][Full Text] [Related]
12. Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
Liu P; McMenamin ÚC; Johnston BT; Murchie P; Iversen L; Lee AJ; Vissers PAJ; Cardwell CR
Br J Cancer; 2020 Jul; 123(2):307-315. PubMed ID: 32367073
[TBL] [Abstract][Full Text] [Related]
13. Gastric acid suppressants and cognitive decline in people with or without cognitive impairment.
Wu CY; Xiong LY; Ouk M; Rabin JS; Herrmann N; Lanctôt KL; Kapral MK; Law M; Cogo-Moreira H; Edwards JD; Swardfager W
Alzheimers Dement (N Y); 2022; 8(1):e12243. PubMed ID: 35169610
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J
J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495
[TBL] [Abstract][Full Text] [Related]
15. Changes in estimated glomerular filtration rate in patients administered proton pump inhibitors: a single-center cohort study.
Murofushi T; Yagi T; Tsuji D; Furushima D; Fujikura T; Itoh K; Kawakami J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; ():. PubMed ID: 38170305
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
[TBL] [Abstract][Full Text] [Related]
17. Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients.
Huang CH; Tseng YH; Tsai WS; Su CC; Cheng CL; Kao Yang YH; Chang YC; Liu YH
Infect Dis Ther; 2024 Feb; 13(2):373-383. PubMed ID: 38286955
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and dementia: A nationwide population-based study.
Pourhadi N; Janbek J; Jensen-Dahm C; Gasse C; Laursen TM; Waldemar G
Alzheimers Dement; 2024 Feb; 20(2):837-845. PubMed ID: 37795826
[TBL] [Abstract][Full Text] [Related]
19. Residential Green Space and Cognitive Function in a Large Cohort of Middle-Aged Women.
Jimenez MP; Elliott EG; DeVille NV; Laden F; Hart JE; Weuve J; Grodstein F; James P
JAMA Netw Open; 2022 Apr; 5(4):e229306. PubMed ID: 35476063
[TBL] [Abstract][Full Text] [Related]
20. Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.
Nevado-Holgado AJ; Kim CH; Winchester L; Gallacher J; Lovestone S
BMJ Open; 2016 Nov; 6(11):e012177. PubMed ID: 27903560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
